As of 2025-07-09, the Relative Valuation of Ryvu Therapeutics SA (RVU.WA) is (116.20) PLN. This relative valuation is based on P/E multiples. With the latest stock price at 30.90 PLN, the upside of Ryvu Therapeutics SA based on Relative Valuation is -476.0%.
The range of the Relative Valuation is (104.32) - (158.51) PLN.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.6x - 34.2x | 26.8x |
| Forward P/E multiples | 16.2x - 31.2x | 19.0x |
| Fair Price | (104.32) - (158.51) | (116.20) |
| Upside | -437.6% - -613.0% | -476.0% |
| Date | P/E |
| 2025-07-04 | -6.31 |
| 2025-07-03 | -6.30 |
| 2025-07-02 | -6.27 |
| 2025-07-01 | -6.39 |
| 2025-06-30 | -6.35 |
| 2025-06-27 | -6.25 |
| 2025-06-26 | -6.16 |
| 2025-06-25 | -6.22 |
| 2025-06-24 | -5.97 |
| 2025-06-23 | -5.92 |
| 2025-06-20 | -6.01 |
| 2025-06-18 | -5.92 |
| 2025-06-17 | -5.85 |
| 2025-06-16 | -5.86 |
| 2025-06-13 | -5.84 |
| 2025-06-12 | -5.87 |
| 2025-06-11 | -5.68 |
| 2025-06-10 | -6.01 |
| 2025-06-09 | -6.00 |
| 2025-06-05 | -5.91 |
| 2025-06-04 | -6.03 |
| 2025-06-03 | -5.90 |
| 2025-06-02 | -6.04 |
| 2025-05-30 | -5.92 |
| 2025-05-29 | -6.13 |
| 2025-05-28 | -6.26 |
| 2025-05-27 | -6.29 |
| 2025-05-26 | -6.21 |
| 2025-05-23 | -5.91 |
| 2025-05-22 | -6.41 |
| 2025-05-21 | -6.43 |
| 2025-05-20 | -6.50 |
| 2025-05-19 | -6.50 |
| 2025-05-16 | -6.53 |
| 2025-05-15 | -6.50 |
| 2025-05-14 | -6.68 |
| 2025-05-13 | -6.74 |
| 2025-05-12 | -6.76 |
| 2025-05-09 | -6.60 |
| 2025-05-08 | -6.34 |
| 2025-05-07 | -6.32 |
| 2025-05-06 | -6.38 |
| 2025-05-05 | -6.63 |
| 2025-05-02 | -6.47 |
| 2025-04-30 | -6.39 |
| 2025-04-29 | -6.49 |
| 2025-04-28 | -6.69 |
| 2025-04-25 | -6.07 |
| 2025-04-24 | -6.24 |
| 2025-04-23 | -6.39 |